New Dawn Bio raised €2.1M in a Pre-Seed round in Jun 2026. The company is based in Wageningen, Netherlands. Investors in the round: CapitalT, Jelle Prins, Norrsken Evolve and 1 other. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €2.1M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
